Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)

NCT04156841 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT04156841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04156841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2019
Completion date
December 31, 2021
Enrollment
21,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, sentinel lymph node